Skip to content
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
The market for gene therapy
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
About CombiGene
Media
Press releases
Presentations
Contact
Contact us
Downloads
SV
Financial calendar
14 February, 2025
Year-end report 2024
22 August, 2025
Interim report January-June 2025
13 February, 2026
Year-end report 2025
12 June, 2025
Annual General Meeting 2025
Financial reports
February 14, 2025
Year-end report January-December 2024 CombiGene AB (Publ)
November 8, 2024
Interim report January – September 2024 for CombiGene AB (publ)
August 23, 2024
Interim report January – June 2024 for CombiGene AB (publ)
May 17, 2024
Interim report January – March 2024 for CombiGene AB (publ)
April 26, 2024
CombiGene AB (publ) publishes annual report for 2023
February 16, 2024
Year-end report January-December 2023 CombiGene AB (Publ)
Load more
